Variable | Northwest Territories | Nunavut | Nunavut without Iqaluit | Kitikmeot Region | Kivalliq Region | Qikiqtaaluk Region | Qikiqtaaluk Region without Iqaluit | Nunavik |
---|---|---|---|---|---|---|---|---|
Base case (no prophylaxis) | ||||||||
Total costs, $ | 177 256 | 2 871 137 | 2 856 561 | 1 496 365 | 1 094 603 | 280 169 | 265 593 | 632 139 |
No. of admissions for RSV infection | 8 | 52 | 51 | 22 | 18 | 12 | 11 | 30 |
Scenario A | ||||||||
Total costs, $ | 4 374 645 | 4 937 207 | 4 256 984 | 733 714 | 1 491 713 | 2 711 781 | 2 031 558 | 1 502 765 |
No. of admissions for RSV infection | 0.3 | 2.1 | 2 | 0.9 | 0.7 | 0.5 | 0.4 | 1.2 |
Scenario B | ||||||||
Total costs, $ | 2 690 852 | 3 457 312 | 3 039 106 | 705 024 | 1 058 004 | 1 694 285 | 1 276 078 | 990 964 |
No. of admissions for RSV infection | 0.3 | 11.7 | 11.6 | 5.7 | 4.6 | 1.4 | 1.4 | 7 |
Scenario A v. base case | ||||||||
Incremental costs, $ | 4 197 389 | 2 066 070 | 1 400 423 | -762 652 | 397 111 | 2 431 611 | 1 765 965 | 870 625 |
Incremental no. of RSV-related admissions | 7.7 | 49.9 | 49 | 21.1 | 17.3 | 11.5 | 10.6 | 28.8 |
ICER (cost per RSV-related admission avoided), $ | 545 115 | 41 404 | 28 580 | -36 145 | 22 954 | 211 444 | 166 600 | 30 230 |
Scenario B v. base case | ||||||||
Incremental costs, $ | 2 513 597 | 586 175 | 182 545 | -791 342 | -36 599 | 1 414 116 | 1 010 486 | 358 825 |
Incremental no. of RSV-related admissions | 7.7 | 40.3 | 39.4 | 16.3 | 13.4 | 10.6 | 9.6 | 23 |
ICER (cost per RSV-related admission avoided), $ | 326 441 | 14 545 | 4633 | -48 549 | -2731 | 133 407 | 105 259 | 15 601 |
Scenario A v. scenario B | ||||||||
Incremental costs, $ | 1 683 793 | 1 479 895 | 1 217 878 | 28 690 | 433 709 | 1 017 496 | 755 480 | 511 801 |
Incremental no. of RSV-related admissions | 0 | 9.6 | 9.6 | 4.8 | 3.9 | 0.9 | 1 | 5.8 |
ICER (cost per RSV-related admission avoided), $ | - | 154 156 | 126 862 | 5977 | 111 207 | 1 130 551 | 755 480 | 88 242 |
Note: ICER = incremental cost-effectiveness ratio, RSV = respiratory syncytial virus.